Sign up
Quantellect · Congress · Trade Detail
NASDAQ: CAMPCAMP4 THERAPEUTICS CORPORATION
RepublicanHouse

James B. Renacci sold CAMP4 THERAPEUTICS CORPORATION (NASDAQ: CAMP)

James B. Renacci (R-OH), a U.S. Representative, has disclosed 2 trades in CAMP4 THERAPEUTICS CORPORATION (CAMP) since 2015, all sales, worth an estimated $65K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: James B. Renacci sold $15,001 - $50,000 of CAMP4 THERAPEUTICS CORPORATION (NASDAQ: CAMP) on October 2, 2015. Since that trade, CAMP is up +98.18% against the S&P 500 up +345.22%, an outperformance of -247.04%.

Across these filings, James B. Renacci has been a net seller of CAMP. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

CAMP trades
2
Disclosed Vol
$65K
Buys
0
0%
Sells
2
100%
Buy / Sell
0.00
ratio
First → Last
2015

James B. Renacci's CAMP trades vs the price

CAMP is up +98.18% since James B. Renacci sold on October 2, 2015, versus +345.22% for the S&P 500.

Performance since this trade

Price change since trade
+98.18%
S&P 500 change since trade
+345.22%
Outperformance vs S&P 500
-247.04%

All James B. Renacci CAMP trades

TradedTypeSizeReturnEst. profit
October 2, 2015SELL$15,001 - $50,000N/A
January 28, 2015SELL$15,001 - $50,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

James B. Renacci & CAMP trading FAQ

Is it legal for James B. Renacci to trade CAMP4 THERAPEUTICS CORPORATION (CAMP) stock?

Yes. Members of Congress are allowed to trade individual stocks, including CAMP4 THERAPEUTICS CORPORATION (CAMP), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did James B. Renacci sell CAMP?

James B. Renacci disclosed a sale of $15,001 - $50,000 of CAMP4 THERAPEUTICS CORPORATION (CAMP) on October 2, 2015, according to public STOCK Act filings.

How has CAMP performed since James B. Renacci's trade?

Since James B. Renacci sold CAMP on October 2, 2015, the stock is up +98.18%, versus +345.22% for the S&P 500 over the same period, an outperformance of -247.04%.

How many times has James B. Renacci traded CAMP?

James B. Renacci has disclosed 2 CAMP trades since 2015. Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional CAMP trades?

Quantellect tracks every disclosed congressional trade in CAMP4 THERAPEUTICS CORPORATION (CAMP) on the CAMP4 THERAPEUTICS CORPORATION congressional trading page, which aggregates filings across all members of Congress.

James B. Renacci's CAMP tradesAll congressional filings for CAMP4 THERAPEUTICS CORPORATIONJames B. Renacci's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.